Association between mutations in a thyX-hsdS.1 region and para-aminosalicylic acid resistance in Mycobacterium tuberculosis clinical isolates. [PDF]
Zeng R +8 more
europepmc +1 more source
Response: Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey". [PDF]
Limsrivilai J, Leung WK.
europepmc +1 more source
Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid. [PDF]
Yarur A +14 more
europepmc +1 more source
Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines. [PDF]
Looser R +7 more
europepmc +1 more source
Current status of 5-aminosalicylic acid in Crohn's disease treatment: a nationwide survey and analysis of perspectives and practice patterns among inflammatory bowel disease physicians. [PDF]
Li Y, Chen C, Wang C.
europepmc +1 more source
Association of Proton Pump Inhibitor and Potassium-Competitive Acid Blocker Use With Discontinuation and Intolerance of Oral 5-Aminosalicylic Acid in Patients With Ulcerative Colitis. [PDF]
Otagiri S +4 more
europepmc +1 more source
Anti-Psoriatic Effects of J2H-1802, a Mycophenolate Mofetil and 5-Aminosalicylic Acid Hybrid, in an Imiquimod-Induced Psoriasis-like Mouse Model. [PDF]
Park SH +10 more
europepmc +1 more source
Prudence is never excessive: Caution warranted in 5-aminosalicylic acid derivatives withdrawal for ulcerative colitis. [PDF]
Gravina AG, Pellegrino R, Federico A.
europepmc +1 more source
Practices and perceptions of 5-aminosalicylic acid use in Crohn's disease: a nationwide survey of physicians in Korea by KASID Guidelines Taskforce Team. [PDF]
Bae JH +18 more
europepmc +1 more source
Optimizing 5-Aminosalicylic Acid Maintenance Treatment in Ulcerative Colitis from the Patient and Physician Perspective: A Cross-sectional Multicenter Study. [PDF]
Amano T +30 more
europepmc +1 more source

